TARG Targanta Therapeutics Corp (MM)

Targanta Therapeutics Corporation (Nasdaq: TARG) today announced its planned participation in the following investor conferences in November 2008: Rodman and Renshaw 10th Annual Healthcare Conference on Tuesday, November 11, 2008 at 5:45p.m. ET at the New York Palace Hotel in New York, NY. Credit Suisse 2008 Healthcare Conference on Friday, November 14, 2008 at 12:00p.m. ET at the Arizona Biltmore in Phoenix, AZ. Lazard Capital Markets 5th Annual Healthcare Conference on Tuesday, November 18, 2008 at 2:40p.m. ET at the St. Regis Hotel in New York, NY. The presentations will be webcast live and will be available for replay for approximately 30 days following the presentations through the Investor Relations section of Targanta�s website at www.targanta.com/investors. About Targanta Therapeutics Targanta Therapeutics Corporation (Nasdaq: TARG) is a biopharmaceutical company focused on developing and commercializing innovative antibiotics to treat serious infections in the hospital and other institutional settings. The Company�s pipeline includes an intravenous version of oritavancin, a semi-synthetic lipoglycopeptide antibiotic currently awaiting U.S. and EU regulatory approval, and, a program to develop an oral version of oritavancin for the treatment of Clostridium difficile. The Company has operations in Cambridge, MA, Indianapolis, IN, and Montreal, Qu�bec, Canada. For more information on Targanta, visit www.targanta.com.